Efficacy of rituximab in hairy cell leukemia.

被引：0
|
作者：
Kokoris, Styliani I. [1 ]
Angelopoulou, Maria K. [1 ]
Galani, Zacharoula I. [1 ]
Anargyrou, Konstantinos [1 ]
Sachanas, Sotirios [1 ]
Vassilakopoulos, Theodoros P. [1 ]
Siakantaris, Marina P. [1 ]
Kontopidou, Flora N. [1 ]
Dimitriadou, Evangelia M. [1 ]
Dimopoulou, Maria N. [1 ]
Tsaftaridis, Panayiotis [1 ]
Plata, Eleni [1 ]
Kalpadakis, Christina [1 ]
Kyrtsonis, Marie. -Christine [1 ]
Panayiotidis, Panayiotis [1 ]
Pangali, Gerassimos A. [1 ]
机构：
[1] Univ Athens, Dept Internal Med 1 & Hematol, Athens, Greece
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4719
引用
收藏
页码：262B / 262B
页数：1
相关论文
共 50 条
  • [1] Efficacy of rituximab in hairy cell leukemia
    Malfuson, Jean-Valere
    Doghmi, Kamal
    Fagot, Thierry
    Souleau, Bertrand
    de Revel, Thierry
    Nedellec, Gerard
    PRESSE MEDICALE, 2006, 35 (05): : 801 - 802
  • [2] Efficacy of rituximab in hairy cell leukemia treatment
    Zinzani, PL
    Ascani, S
    Piccaluga, PP
    Bendandi, M
    Pileri, S
    Tura, S
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (22) : 3875 - 3877
  • [3] Treatment of hairy cell leukemia.
    Volkova, MA
    Lepkov, SV
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 1997, 42 (03): : 15 - 20
  • [4] Blastic transformation of hairy cell leukemia.
    Islam, A
    Bielat, K
    Akhter, S
    Plavsic, L
    Ambrus, J
    BLOOD, 2000, 96 (11) : 224B - 224B
  • [5] EFFICACY OF RITUXIMAB-THERAPY IN RELAPSED OR REFRACTORY HAIRY CELL LEUKEMIA
    Cheveresan, L.
    Cheveresan, M.
    Ionta, H.
    Nicola, D.
    Calamar, D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 527 - 527
  • [6] Efficacy and safety of cladribine: Subcutaneous versus intravenous administration in hairy cell leukemia.
    Mohamed, Tarek Yakout
    El Gammal, Mosaad
    Namour, Alfred Elias
    Malek, Raafat Ragaie Abdel
    Khorshid, Ola
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [7] VH gene expression in hairy cell leukemia.
    Maloum, K
    Magnac, C
    Azgui, Z
    Charlotte, F
    Cau, C
    Binet, JL
    MerleBeral, H
    Dighiero, G
    BLOOD, 1996, 88 (10) : 298 - 298
  • [8] Rituximab in relapsed or refractory hairy cell leukemia
    Thomas, DA
    O'Brien, S
    Bueso-Ramos, C
    Faderl, S
    Keating, MJ
    Giles, FJ
    Cortes, J
    Kantarjian, HM
    BLOOD, 2003, 102 (12) : 3906 - 3911
  • [9] Randomized phase II study of cladribine with simultaneous or delayed rituximab in patients with untreated hairy cell leukemia.
    Chihara, Dai
    Arons, Evgeny
    Stetler-Stevenson, Maryalice
    Yuan, Constance
    Zhou, Hong
    Raffeld, Mark
    Xi, Liqiang
    Steinberg, Seth M.
    Wisch, Laura
    Feurtado, Julie
    James-Echenique, Lacey
    Braylan, Raul
    Calvo, Katherine R.
    Maric, Irina
    Dulau, Alina
    Kreitman, Robert J.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [10] Immunophenotypic analysis in 10 cases of hairy cell leukemia.
    Ionita, H
    Isac, A
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 477 - 477
12345